Authors



David Brody, MD

Latest:

Postdischarge Telephone Calls by Hospitalists as a Transitional Care Strategy

Treating hospitalists effectively identify and efficiently address early postdischarge problems through a single, brief telephone encounter.



Lane Burgette, PhD

Latest:

Are Value-Based Incentives Driving Behavior Change to Improve Value?

Value-based payment is promoting care delivery transformation among California physician organizations, although the initial focus has been on controlling hospital costs and redesigning primary care.



Dina Appleby, MS

Latest:

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.


Brandy D. McGinnis, PharmD

Latest:

Statin Adherence and Mortality in Patients Enrolled in a Secondary Prevention Program

Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.


S. Patrick Hammond, MHA

Latest:

A Model for Delivering Population Health Across the Care Continuum

The Population Health Care Delivery Model presents delivery systems with a framework for developing, piloting, and implementing population health programs across the continuum of care.


Kari L. Olson, PharmD

Latest:

Systolic Blood Pressure Control After Participation in a Hypertension Intervention Study

Systolic blood pressure control was not maintained in a large proportion of patients after the end of participation in a hypertension intervention study.


Dawn Holcombe, FACMPE, MBA

Latest:

Oncology Management Programs for Payers and Physicians

Evaluating current models and diagnosing successful strategies for payers and physicians.



Jessica Frank, PharmD

Latest:

Stimulating Comprehensive Medication Reviews Among Medicare Part D Beneficiaries

This article describes a study of an intervention to engage Medicare Part D beneficiaries in obtaining a comprehensive medication review.




Ashby F. Walker, PhD

Latest:

Geographic Access to Endocrinologists for Florida's Publicly Insured Children With Diabetes

Enrollment, claims, and spatial data are used to demonstrate the importance of outreach strategies for families in rural areas who have children with diabetes. Spatial barriers, alone, do not fully elucidate racial/ethnic disparities in pediatric diabetes for street-level location. (For Tables and the Figure, please access the PDF on the last page.)





Alex Pedan, PhD

Latest:

Assessment of Drug Consumption Patterns for Medicare Part D Patients

This retrospective cohort study found that a sizable proportion of standard Medicare Part D drug program beneficiaries reached the “doughnut hole.”


Kenneth E. Kudrak, ASA, MS, MA

Latest:

Medication Adherence for 90-Day Quantities of Medication Dispensed Through Retail and Mail Order Pharmacies

Patients' adherence to maintenance medications at retail pharmacy is slightly higher than those at mail order, presenting opportunities for pharmacists to provide quality care.





Chad Moretz, ScD, MS

Latest:

Health Care Resource Utilization Among Patients With T2D and Cardiovascular-, Heart Failure–, or Renal-Related Hospitalizations

Among patients with type 2 diabetes (T2D), concurrent cardiovascular-, heart failure–, or renal-related hospitalization presents significant disease burden leading to poor quality of life.




Tugba Cayirli, PhD

Latest:

FASStR: A Framework for Ensuring High-Quality Operational Metrics in Health Care

Through literature review and collaborative design, we propose the Focus, Activity, Statistic, Scale type, and Reference (FASStR) framework to provide a systematic approach to health care operation metric definition and use.



John M. Brooks, PhD

Latest:

Effects of Health Savings Account Eligible Plans on Utilization and Expenditures

The health savings account-eligible design may decrease costs and utilization, but it also may decrease use of preventive services.


Christine G. Kohn, PharmD

Latest:

Humanistic and Economic Burden of Hepatocellular Carcinoma: Systematic Literature Review

Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo